Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries.

PubWeight™: 2.48‹?› | Rank: Top 2%

🔗 View Article (PMID 11432883)

Published in J Clin Oncol on July 01, 2001

Authors

T R Möller1, S Garwicz, L Barlow, J F Winther, E Glattre, G Olafsdottir, J H Olsen, R Perfekt, A Ritvanen, R Sankila, H Tulinius, Association of the Nordic Cancer Registries, Nordic Society for Pediatric Hematology and Oncology

Author Affiliations

1: Department of Cancer Epidemiology, University Hospital, Lund, Sweden. torgil.moller@cancerepid.lu.se

Articles citing this

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst (2008) 5.05

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol (2009) 3.30

Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol (2008) 3.27

Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA (2009) 2.42

Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. N Engl J Med (2016) 2.36

A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med (2010) 2.28

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood (2008) 2.17

Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol (2008) 2.04

Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst (2009) 2.03

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol (2010) 1.84

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. Lancet Oncol (2010) 1.52

Health status of adolescent and young adult cancer survivors. Cancer (2012) 1.44

Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst (2010) 1.38

Temporal trends in cause-specific late mortality among 5-year survivors of childhood cancer. J Clin Oncol (2010) 1.27

Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med (2014) 1.26

Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood (2008) 1.21

Early and late mortality after diagnosis of wilms tumor. J Clin Oncol (2009) 1.12

Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol (2012) 1.12

Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol (2011) 1.07

Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol (2013) 1.07

Secondary malignancies across the age spectrum. Semin Radiat Oncol (2010) 1.04

National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biol Blood Marrow Transplant (2011) 1.01

Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol (2013) 0.99

Late mortality in childhood cancer: two excellent studies bring good news tempered by room for improvement. J Clin Oncol (2001) 0.93

Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J R Soc Med (2014) 0.92

Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes. Pediatrics (2012) 0.86

Cardiovascular effects in childhood cancer survivors treated with anthracyclines. Cardiol Res Pract (2011) 0.86

Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ (2016) 0.84

Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer (2011) 0.83

Childhood leukaemia: long-term excess mortality and the proportion 'cured'. Br J Cancer (2008) 0.82

Up-to-date survival curves of children with cancer by period analysis. Br J Cancer (2003) 0.80

Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study. Pediatr Cardiol (2012) 0.78

Risk of Late Mortality and Second Malignant Neoplasms among 5-Year Survivors of Young Adult Cancer: A Report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research Program. J Cancer Epidemiol (2012) 0.78

Estimation of potential excess cancer incidence in pediatric 201Tl imaging. AJR Am J Roentgenol (2010) 0.78

Testicular cancer: a narrative review of the role of socioeconomic position from risk to survivorship. Urol Oncol (2011) 0.77

Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia. BMC Med Res Methodol (2013) 0.75

Population-Based Long-Term Cardiac-Specific Mortality Among 34,489 Five-Year Survivors of Childhood Cancer in Great Britain. Circulation (2017) 0.75

Cause-specific long-term mortality in survivors of childhood cancer in Switzerland: A population-based study. Int J Cancer (2016) 0.75

Predicting Organ-Specific Risk Interactions between Radiation and Chemotherapy in Secondary Cancer Survivors. Cancers (Basel) (2017) 0.75

Articles by these authors

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67

The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med (1998) 4.41

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet (1996) 4.38

Induced abortion and the risk of breast cancer. N Engl J Med (1997) 4.04

Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst (1997) 3.57

A pooled analysis of magnetic fields and childhood leukaemia. Br J Cancer (2000) 3.49

Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med (1996) 3.18

Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17

Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer (1995) 2.82

Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67

Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst (2001) 2.59

Screening for cancer of the uterine cervix in Iceland 1965--1978. Acta Obstet Gynecol Scand (1982) 2.57

Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer (1977) 2.56

Rheumatoid arthritis and cancer risk. Eur J Cancer (1996) 2.44

Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35

Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer (1994) 2.33

Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet (1997) 2.28

Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol (2000) 2.18

Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14

A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control (1999) 2.08

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07

Malignant tumours and psoriasis: climatotherapy at the Dead Sea. Br J Dermatol (1999) 2.06

Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. J Med Genet (2003) 2.03

Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment. Pediatr Hematol Oncol (1992) 1.99

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer (2003) 1.88

Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87

Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology (2009) 1.86

Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84

Non-neoplastic mortality of European workers who produce man made vitreous fibres. Occup Environ Med (1999) 1.83

Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control (2001) 1.82

Air pollution from traffic at the residence of children with cancer. Am J Epidemiol (2001) 1.79

Incidence of cancer among commercial airline pilots. Occup Environ Med (2000) 1.79

Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol (2002) 1.74

Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (2000) 1.73

A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control (2000) 1.70

Benign anal lesions and the risk of anal cancer. N Engl J Med (1994) 1.67

Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries. Acta Pathol Microbiol Immunol Scand Suppl (1986) 1.60

Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol (2001) 1.59

Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer (2002) 1.59

Multiple sclerosis in Rochester, Minn. A 60-year appraisal. Arch Neurol (1971) 1.58

Incidence of childhood cancer in Denmark 1943-1984. Int J Epidemiol (1989) 1.54

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) Acta Paediatr (1998) 1.53

Carcinoma of the parotid and submandibular glands--a study of survival in 2465 patients. Oral Oncol (2002) 1.51

Long-term survival in idiopathic membranous glomerulonephritis: can the course be clinically predicted? Clin Nephrol (1994) 1.51

A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control (1999) 1.50

Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies. Leukemia (2001) 1.50

Cancer following breast reduction surgery in Denmark. Cancer Causes Control (1997) 1.50

Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum (1997) 1.49

Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control (1995) 1.47

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer (2000) 1.46

High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands. Br J Cancer (1998) 1.45

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ (1993) 1.44

A genetic study of ulcerative colitis. Scand J Gastroenterol (1966) 1.42

Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut (1988) 1.42

Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year. Br J Cancer (1997) 1.40

Malignant melanoma among lithographers. Scand J Work Environ Health (1996) 1.40

Idiopathic pulmonary haemosiderosis in Swedish children. Acta Paediatr Scand (1984) 1.39

Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst (1997) 1.39

Reproductive factors and risk for breast cancer in Iceland. Int J Cancer (1978) 1.39

A decline in the lung cancer incidence amongst men in Swedish cities. Acta Oncol (1996) 1.39

[Pernicious anemia and risk of cancer in Denmark]. Ugeskr Laeger (1997) 1.39

Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol (1998) 1.39

Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer (2000) 1.36

A novel approach to estimate the proportion of hereditary nonpolyposis colorectal cancer of total colorectal cancer burden. Cancer Detect Prev (1994) 1.36

Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int J Cancer (1996) 1.33

Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer (2001) 1.33

Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol (1998) 1.33

Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract? Cancer (1999) 1.31

Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31

Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer (1999) 1.29

Cancer in patients with ulcerative colitis. Int J Cancer (1995) 1.28

An air pollution model for use in epidemiological studies: evaluation with measured levels of nitrogen dioxide and benzene. J Expo Anal Environ Epidemiol (2000) 1.27

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood (2002) 1.27

European health systems and cancer care. Ann Oncol (2003) 1.27

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer (2009) 1.26

Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs. J Clin Microbiol (2000) 1.25

Connective tissue disease and other rheumatic conditions following breast implants in Denmark. Ann Plast Surg (1997) 1.24

Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control (2002) 1.23

Occurrence of different cancers in patients with Parkinson's disease. BMJ (1995) 1.23

Summary: multiple primary cancers in Denmark, 1943-80. Natl Cancer Inst Monogr (1985) 1.23